StocksDeepDive
Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

JAZZ — Jazz Pharmaceuticals plc

UNDERVALUED (MOS +56.2%) · Quality 57/100

Value Score 30 days ago: 42.7 → today 36.2

Price
248.24
Intrinsic value
567
Margin of safety
+56.2%
Implied growth (reverse DCF)
-0.6%
model assumes +13.9%
Value Score
36.2
Quality
57
Psychology
-17.6
Discovery
12.5
price/volume attention only
Moat score
31
erosion: none

Value Score: top 22% of Russell 3000 · Quality: bottom 32%

Open the interactive Deep Dive for JAZZ →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/JAZZ - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is JAZZ undervalued?

As of 2026-11-11, JAZZ trades at 248.24 against a computed intrinsic value of 567 (+56.2% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Jazz Pharmaceuticals plc's Value Score?

Jazz Pharmaceuticals plc's Value Score is 36.2 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.